CWK

Cushman & Wakefield

$12.59

-2.33%
Nov 20, 2026
Bobby Quantitative Model
Cushman & Wakefield is a global commercial real estate services firm operating across roughly 400 offices in 60 countries with approximately 53,000 employees, delivering leasing, capital markets, property management, and project management services to occupiers, owners, and investors across office, industrial, retail, and data center property types. Formed through a transformative 2015 merger with DTZ and taken public in 2018, the firm sits in the second tier of the CRE services oligopoly behind CBRE and JLL, competing on global footprint and capital markets execution rather than scale leadership. The current investor debate centers on whether the company can convert a cyclical transaction-recovery into durable earnings power: Q3 2026 revenue grew 7.75% year-over-year to $2.81 billion and gross margin expanded to 17.3% from 16.4%, yet trailing net margins remain razor-thin at roughly 0.9% and the stock has badly lagged the market over the past year. A sharp November rally following Q3 results (filed November 4) has refocused attention on the leverage story — high debt, thin interest coverage, and a bet that a capital markets rebound will flow through to EPS.

People also watch

CBRE Group

CBRE Group

CBRE

Analysis
Jones Lang LaSalle

Jones Lang LaSalle

JLL

Analysis
CoStar Group

CoStar Group

CSGP

Analysis
Compass RE

Compass RE

COMP

Analysis
Opendoor

Opendoor

OPEN

Analysis

BobbyInvestment Opinion: Should I buy CWK Today?

Rating: Hold with a constructive lean. The core thesis is that CWK is a cheap, cash-generative cyclical recovery story (roughly 5.4x consensus FY2026 EPS of $2.45 at $13.30) whose upside is capped by a leveraged balance sheet — 1.66x debt-to-equity, 2.64x interest coverage, and $49.2 million of quarterly interest expense consuming about 59% of Q3 pre-tax income — so the low multiple is a rational discount until margin durability is proven. Analyst consensus is moderately bullish (three Buy-equivalents from Goldman, Morgan Stanley, and Citizens versus two Neutral/Hold from Barclays and UBS, zero Sells, and a Citigroup upgrade in November 2025), but with no published consensus price target the upside cannot be anchored.

Supporting evidence is genuinely two-sided. On the positive side, Q3 2026 revenue grew 7.75% YoY to $2.81 billion (from $2.61 billion) with gross margin expanding to 17.32% from 16.43% and operating income rising to $129.9 million from $107.5 million; TTM free cash flow of $232.5 million (including $176.1 million in Q3 alone on just $37.8 million of capex) funds deleveraging, with $52.1 million of debt repaid and $506.5 million of cash on hand. On the negative side, trailing net margin is 0.86%, operating margin 4.46%, ROE 4.51%, and the quarterly record includes losses in Q1 2026 (-$12.6 million) and Q4 2025 (-$22.4 million); the 14.27x EV/EBITDA looks full against a 4.46% operating margin, and the stock has lagged the S&P 500 by 26.63 percentage points over twelve months.

The rating would upgrade to Buy if gross margin holds at or above 17% for a second consecutive quarter while capital markets transaction volumes keep recovering, pushing EPS toward the $2.51 high estimate (about 5.3x at $13.30), or if interest coverage improves above 3x through debt paydown. It would downgrade to Sell if gross margin reverts toward the 14.6% Q1 2026 level, if interest coverage falls below 2x, or if the stock breaks below the $11.04 October low. On valuation, CWK is cheap on sales (0.36x PS versus a historical 0.76x-1.98x band) and book (1.91x versus a 1.10x-3.43x range) but expensive on EV/EBITDA relative to its margins — net, the stock screens as undervalued on forward earnings and sales but fairly-to-fully valued once leverage and thin profitability are priced in, which supports Hold rather than Buy.

Sign up to view all

CWK 12-Month Price Forecast

CWK presents a classic deep-value cyclical setup: an extremely low ~5.4x forward earnings multiple and 0.36x PS ratio against a genuine revenue and margin recovery (7.75% YoY growth, gross margin up 89 basis points to 17.32%) and robust $232.5 million TTM free cash flow. The offset is a leveraged balance sheet where 2.64x interest coverage and $49.2 million of quarterly interest expense leave little cushion, and a quarterly record that includes losses in Q1 2026 and Q4 2025 — so the market's discount is rational until margin durability is proven. Analyst sentiment is constructive but shallow, with only six analysts and no published targets, and the stock's -26.63 percentage point one-year relative-strength gap versus the S&P 500 underscores how much damage the downtrend has done. We would upgrade to bullish if gross margin holds at or above 17% for a second consecutive quarter and interest coverage improves above 3x, and downgrade to bearish if gross margin rolls back toward 14.6% or the stock breaks below $11.04.

Historical Price
Current Price $12.59
Average Target $12.59
High Target $14.48
Low Target $10.70

Wall Street consensus

Six analysts cover CWK, and the institutional ratings skew constructive: Goldman Sachs reiterated Buy on November 12, Morgan Stanley maintained Overweight and Citizens maintained Market Outperform on October 22, while Barclays (Equal Weight) and UBS (Neutral) sit on the sidelines — implying roughly three Buy-equivalent ratings against two Neutral/Hold and no Sells, a moderately bullish consensus. Consensus EPS estimates average $2.45 (range $2.41-$2.51) on average revenue of $13.54 billion (range $13.36-$13.79 billion); however, no consensus price target is provided in the data, so implied upside cannot be calculated — a notable gap given the stock's 20% one-month rally. The recent direction of travel is positive, with Citigroup upgrading to Buy from Neutral in November 2025 and no downgrades in the past year.

The estimate range is remarkably tight — EPS spans just $2.41 to $2.51 (a ~4% spread) and revenue spans $13.36 billion to $13.79 billion (a ~3% spread) — signaling strong conviction in the near-term earnings trajectory, which contrasts sharply with the stock's high price volatility (max drawdown -35.81%). The high-end EPS of $2.51 would imply roughly 5.3x forward earnings at $13.30, while the low end of $2.41 implies 5.5x; both suggest the market is discounting the estimates heavily, likely due to leverage and interest-coverage concerns rather than revenue uncertainty. With only six analysts and no published target prices, coverage is moderate rather than deep, which limits price-discovery efficiency and can amplify moves around earnings — investors should treat the tight estimate spread as a signal of operational confidence but the absence of targets as a constraint on upside anchoring.

Drowning in data?

Find the real signal!

Bulls vs Bears: CWK Investment Factors

The bear case currently has stronger evidence on the balance sheet — 1.66x debt-to-equity, 2.64x interest coverage, and interest expense eating ~59% of pre-tax income — while the bull case rests on a genuine but early revenue and margin recovery (7.75% YoY growth, gross margin up to 17.32%) and a strikingly cheap ~5.4x forward EPS multiple. The most important tension is whether the Q3 margin expansion is durable: if gross margin holds near 17% and capital markets activity keeps recovering, operating leverage on a fixed-cost base could drive EPS well above the $2.45 consensus and re-rate the stock; if margins roll back toward the 14.6% Q1 level, the low multiple is a rational discount for structural leverage. Analyst sentiment (three Buy-equivalents, no Sells, a Citigroup upgrade) and the 20.47% one-month rally tilt modestly constructive, but the absence of published price targets and the -26.63% one-year relative-strength gap argue for caution. Net, the evidence is balanced with a slight edge to the bulls on valuation and momentum, contingent entirely on margin durability.

Bullish

  • Forward EPS implies ~5.4x multiple: Consensus FY2026 EPS of $2.45 (tight $2.41-$2.51 range across six analysts) implies roughly 5.4x forward earnings at $13.30, an extremely depressed multiple for a global services franchise. The ~4% spread between high and low EPS estimates signals unusually high conviction in the near-term earnings trajectory, suggesting the discount is about leverage, not revenue uncertainty.
  • Revenue recovery with margin expansion: Q3 2026 revenue rose 7.75% YoY to $2.81 billion from $2.61 billion, extending a sequential climb from $2.54 billion in Q1 and $2.76 billion in Q2. Gross margin expanded to 17.32% from 16.43% a year earlier and operating income jumped to $129.9 million from $107.5 million, evidence that operating leverage is beginning to flow through.
  • Strong free cash flow funds deleveraging: TTM free cash flow is $232.5 million, with Q3 2026 alone generating $176.1 million of FCF on $213.9 million operating cash flow against just $37.8 million of capex. The company repaid $52.1 million of debt in Q3 and holds $506.5 million of cash, giving it self-funding capacity to reduce the 1.66x debt-to-equity burden.
  • Constructive analyst consensus, no sells: Six analysts split roughly three Buy-equivalent (Goldman Buy, Morgan Stanley Overweight, Citizens Market Outperform) against two Neutral/Hold (Barclays, UBS) and zero Sells. Citigroup upgraded to Buy from Neutral in November 2025 with no downgrades in the past year, and the direction of travel in ratings is positive.

Bearish

  • Leverage and thin interest coverage: Debt-to-equity stands at 1.66x with total debt at 58.7% of capitalization, and interest coverage of just 2.64x leaves minimal cushion. Quarterly interest expense of $49.2 million consumes roughly 59% of Q3 pre-tax income of $83.7 million, so any rate or refinancing shock hits EPS directly.
  • Razor-thin net margins: Trailing net margin is only 0.86% and Q3 net margin 1.86%, with operating margin of 4.46% and ROE of just 4.51% — well below any reasonable cost of equity. The 14.27x EV/EBITDA looks full against a 4.46% operating margin, and the trailing PE of 42.6x is distorted by depressed earnings.
  • Earnings volatility and loss quarters: Q1 2026 posted a $12.6 million net loss and Q4 2025 a $22.4 million loss, showing the business swings between profit and loss across the cycle. The max drawdown of -35.81% over the period underscores how violently the equity reprices when transaction volumes stall.
  • Severe long-term underperformance: CWK is down 14.36% over the past year and 16.04% YTD versus the S&P 500's +12.27% one-year return, a relative-strength gap of -26.63 percentage points. The three-month change of -7.64% still lags SPY's -2.83%, so the recovery is recent and unproven against a persistent downtrend.

CWK Technical Analysis

CWK is in a recovery phase within a broader downtrend: the stock is down 14.36% over the past year and 16.04% year-to-date, badly trailing the S&P 500's +12.27% one-year return (relative strength of -26.63% over 12 months). At $13.30, the stock sits roughly 86.5% of the way up its 180-day range of approximately $11.04 (October 14 low) to $15.37 (August 19 high), meaning it has reclaimed most of its autumn drawdown but remains about 13.5% below the period high. This positioning signals improving momentum rather than overextension — the stock is neither a falling knife nor stretched at highs.

Short-term momentum is decisively positive and diverging from the longer-term trend: CWK has gained 20.47% over the past month versus a -2.26% decline in SPY, producing a relative strength of +22.73 percentage points, while the three-month change of -7.64% still lags SPY's -2.83%. The November surge — from $12.62 on October 28 to $14.93 on November 4 and $13.30 by November 13 — followed the Q3 earnings release and reflects a violent mean-reversion rally off the $11.04 October low, though the pullback from the $14.93 spike suggests some profit-taking. The 6-month change of +6.83% versus SPY's +2.13% confirms the intermediate trend has turned constructive even as the 1-year picture remains negative.

Key technical levels are well defined: support sits at the October low near $11.04, with secondary support around $11.75-$12.00, while resistance is the August high of $15.37 and the November 4 intraday spike near $14.93. A breakout above $15.37 would confirm a trend reversal and likely target the prior-year highs, whereas a breakdown below $11.04 would signal the recovery was a failed bounce and reopen downside. The maximum drawdown of -35.81% over the period underscores the stock's high volatility, and with a debt-to-equity ratio of 1.66 and no dividend, position sizing should assume equity-like beta well above the market given the 20%+ monthly swings observed.

Beta

—

—

Max Drawdown

-35.8%

Largest decline past year

52-Week Range

—

Price range past year

Annual Return

-14.6%

Cumulative gain past year

PeriodCWK ReturnS&P 500
1m+8.7%-9.7%
3m-15.0%-9.9%
6m-2.3%-7.5%
1y-14.6%+4.7%
ytd-20.5%+1.2%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

CWK Fundamental Analysis

Revenue is growing at a solid clip: Q3 2026 revenue of $2.81 billion rose 7.75% year-over-year from $2.61 billion, extending a sequential progression from $2.54 billion in Q1 and $2.76 billion in Q2, with the trailing four-quarter run-rate near $11.0 billion against consensus FY2026 estimates of $13.54 billion. The trajectory is one of steady mid-single-digit acceleration driven by leasing and capital markets activity rather than a single segment breakout (segment data not available), and the consistency across quarters — Q1 $2.54B, Q2 $2.76B, Q3 $2.81B — suggests the cyclical trough in transaction volumes has passed. For the investment case, this top-line recovery is the necessary precondition for operating leverage to materialize given the firm's fixed-cost-heavy service model.

Profitability is thin but improving: Q3 2026 net income was $52.1 million (a 1.86% net margin) on gross profit of $486.3 million (17.32% gross margin), up from $51.4 million and a 16.43% gross margin in Q3 2025, while operating income rose to $129.9 million (4.63% operating margin) from $107.5 million. The quarterly pattern is choppy — Q1 2026 posted a $12.6 million net loss and Q4 2025 a $22.4 million loss — reflecting seasonal and transaction-driven swings, but the trailing net margin of 0.86% and operating margin of 4.46% are structurally low for a services business, constrained by $49.2 million of quarterly interest expense that consumes roughly 59% of pre-tax income. Margin expansion, not revenue growth, is the key swing factor for EPS given the 16.2% gross margin base.

Balance sheet leverage is the central risk: debt-to-equity stands at 1.66x with total debt at 58.7% of capitalization and long-term debt at 53.5% of capitalization, while interest coverage of 2.64x leaves limited cushion. Positively, free cash flow is robust — $232.5 million TTM, with Q3 2026 FCF of $176.1 million on operating cash flow of $213.9 million against just $37.8 million of capex — and cash of $506.5 million provides liquidity, though the reported current ratio of 22.76 is a data artifact and the more meaningful quick ratio is 1.06. ROE of 4.51% is weak relative to the cost of equity, and the firm depends on internally generated cash plus modest debt paydown ($52.1 million repaid in Q3) rather than external financing, but the 1.66x leverage and 2.64x coverage mean refinancing risk remains a live overhang.

Quarterly Revenue

$2.8B

2026-09

Revenue YoY Growth

+7.8%

YoY Comparison

Gross Margin

17.3%

Latest Quarter

Free Cash Flow

$232500000.0B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Open an Account, get $2 TSLA now!

Valuation Analysis: Is CWK Overvalued?

Because trailing net income is positive ($52.1 million in Q3, TTM EPS of $0.0236), the PE ratio is the appropriate primary metric, and it tells a confusing story: the trailing PE of 42.6x is elevated, but the forward PE of -1.28x is a data anomaly (negative PEG of -1.28) that should be disregarded in favor of the consensus EPS estimate of $2.45, which implies a forward multiple of roughly 5.4x at $13.30 — a gap that suggests the market is pricing substantial skepticism about earnings delivery or that the trailing figure is distorted by one-off items.

On the more reliable sales-based metric, CWK trades at a PS ratio of 0.36x and price-to-book of 1.91x, with EV/EBITDA at 14.27x — the PS multiple is strikingly low for a $3.36 billion market-cap firm generating roughly $11 billion in revenue, reflecting the market's discount for thin 0.86% net margins and 1.66x leverage. Industry-average multiples for CRE services peers are not provided in the valuation data, so a precise premium/discount spread cannot be quantified; however, a 0.36x PS and 1.91x PB are consistent with a low-margin, capital-light services model trading at a discount to asset-heavy or higher-margin peers, and the 14.27x EV/EBITDA looks full relative to the 4.46% operating margin.

Historical context is instructive: CWK's PS ratio has ranged from roughly 0.76x (Q3 2023) to 1.98x (Q1 2022) over the past several years, and the current 0.36x sits at the very bottom of that band — well below the 1.13x reading in Q2 2026 and the 1.29x in Q4 2025. Similarly, the PB of 1.91x is near the low end of its 1.10x-3.43x historical range, while the trailing PE of 42.6x is distorted by depressed earnings. The market is pricing in either continued margin deterioration or balance-sheet stress; if the Q3 margin expansion proves durable, the stock is cheap on sales and book, but the low multiple may also be a rational discount for 2.64x interest coverage and 4.51% ROE.

PE

42.6x

Latest Quarter

vs. Historical

High-End

5-Year PE Range 7x~43x

vs. Industry Avg

27.2x

Industry PE ~27.2x*

EV/EBITDA

14.3x

Enterprise Value Multiple

Investment Risk Disclosure

Financial and operational risks center on the balance sheet and margin fragility. Debt-to-equity of 1.66x with total debt at 58.7% of capitalization and interest coverage of only 2.64x means $49.2 million of quarterly interest expense absorbs roughly 59% of Q3 pre-tax income, leaving little room for a revenue stumble. Margins are structurally thin — trailing net margin 0.86%, operating margin 4.46%, ROE 4.51% — and the quarterly record shows losses in Q1 2026 (-$12.6 million) and Q4 2025 (-$22.4 million), so earnings are highly cyclical and dependent on transaction volumes. Revenue is also concentrated in cyclical leasing and capital markets activity, and the 14.27x EV/EBITDA multiple leaves little valuation cushion if operating margin compresses from its current 4.46%.

Market and competitive risks include valuation compression and sector rotation. CWK trades at a 0.36x PS ratio at the very bottom of its historical 0.76x-1.98x band, which could reflect a rational discount for leverage rather than an opportunity, and the trailing PE of 42.6x is distorted by depressed earnings while the forward PE of -1.28x is a data anomaly. The stock's high volatility — a -35.81% max drawdown and 20%+ monthly swings — implies equity beta well above the market, so a rotation out of cyclical real estate services or a rise in rates would hit it disproportionately. Competitive pressure from larger peers CBRE and JLL, which have greater scale, and the absence of published analyst price targets with only six covering analysts limit price-discovery support and can amplify post-earnings moves, as seen in the November spike to $14.93 followed by a pullback to $13.30.

The worst-case scenario is a capital markets recovery that stalls while refinancing costs rise: transaction volumes flatten, gross margin reverts toward the 14.6% Q1 2026 level, interest expense stays near $49 million per quarter, and EPS falls short of the $2.45 consensus, forcing the market to reprice the leverage discount. In that chain, the stock would likely retest its 52-week low of $11.04 (hit October 14 and 19, 2026), which from the current $13.30 represents roughly a -17% decline, and a break below that level would reopen the -35.81% max-drawdown path toward the high-$8s to $9 range, implying losses of -30% or more. With no dividend to cushion total return and no analyst bear-case target published, investors should size positions assuming a realistic downside of -17% to the 52-week low and up to -35% in a full cyclical reversal.

FAQ

The most severe risk is financial leverage: 1.66x debt-to-equity with total debt at 58.7% of capitalization and 2.64x interest coverage means $49.2 million of quarterly interest expense absorbs roughly 59% of Q3 pre-tax income, so a revenue stumble or refinancing shock hits EPS directly. Second is earnings volatility — net losses of $12.6 million in Q1 2026 and $22.4 million in Q4 2025, plus a -35.81% max drawdown, show how violently the equity reprices when transaction volumes stall. Third is competitive and cyclical exposure: CWK sits behind larger peers CBRE and JLL in the CRE services oligopoly, and revenue depends on cyclical leasing and capital markets activity. Fourth is coverage and price-discovery risk — only six analysts cover the name with no published price targets, which can amplify post-earnings moves, as seen in the November spike to $14.93 followed by a pullback to $13.30.

The 12-month outlook splits into three scenarios. The base case (50% probability) targets $13.00-$15.37, assuming revenue near the $13.54 billion consensus and EPS near $2.45 with gross margin in the 16-17% range. The bull case (25% probability) targets $15.37-$17.50, requiring gross margin to hold at or above 17.3% and EPS to approach the $2.51 high estimate, driving a re-rating above the August 19 high of $15.37. The bear case (25% probability) targets $9.00-$11.04, assuming margin reversion toward the 14.6% Q1 level and EPS below the $2.41 low estimate, retesting the October low and potentially reopening the -35.81% drawdown path. The base case is most likely, with the key assumption being that the Q3 operating leverage gains hold rather than reverse.

The answer depends on the metric, but the weight of evidence points to undervaluation on forward earnings and sales offset by a rational leverage discount. At $13.30, the stock trades at roughly 5.4x consensus EPS of $2.45 and 0.36x PS — the very bottom of its historical 0.76x-1.98x PS band and far below the 1.13x reading in Q2 2026 — while 1.91x PB sits near the low end of its 1.10x-3.43x range. The 42.6x trailing PE is not a premium signal but a reflection of depressed trailing EPS of $0.0236, and the 14.27x EV/EBITDA looks full against a 4.46% operating margin. The market is pricing in continued margin fragility and balance-sheet stress: 2.64x interest coverage and a 4.51% ROE justify some discount, but if Q3's 17.32% gross margin proves durable, the stock is cheap on sales and forward earnings. Net, it screens as undervalued on forward earnings and sales but fairly-to-fully valued once leverage and thin profitability are priced in.

The risk/reward is asymmetric but conditional. On the upside, CWK trades at roughly 5.4x consensus FY2026 EPS of $2.45 (a tight $2.41-$2.51 range across six analysts) and 0.36x sales, with three Buy-equivalent ratings, zero Sells, a Citigroup upgrade in November 2025, and a 20.47% one-month rally that beat SPY by 22.73 percentage points. On the downside, 1.66x debt-to-equity, 2.64x interest coverage, and $49.2 million of quarterly interest expense consuming about 59% of Q3 pre-tax income mean a revenue stumble hits EPS directly, and the stock has a -35.81% max drawdown with no dividend to cushion returns. A realistic path back to the $11.04 October low is roughly -17%, and a full cyclical reversal could cost -35%. It is a good buy primarily for risk-tolerant value investors with an 18-24 month horizon who believe the Q3 gross margin expansion to 17.32% is durable; conservative investors or those needing income should wait for a second quarter of margin confirmation.

CWK is better suited to a long-term holding period of at least 18-24 months than to short-term trading, given its high volatility and the time needed for a capital markets recovery to flow through to EPS. The stock has no dividend (0% yield, 0% payout), so total return depends entirely on price appreciation, and its 20%+ monthly swings and -35.81% max drawdown make short-term positioning highly risky without tight risk controls. Earnings visibility is limited by cyclical transaction volumes and quarterly losses in Q1 2026 and Q4 2025, though the tight $2.41-$2.51 analyst EPS range signals near-term operational confidence. A patient investor with a 2-3 year horizon could accumulate on weakness toward the $11.04-$12.00 support zone, while short-term traders should focus on the $15.37 resistance and $11.04 support levels.